课题基金 / 基金详情

铁硫蛋白CISD2通过代谢重编程调控Keap1-NRF2-FTH信号轴介导RAS突变肿瘤细胞铁死亡的机制研究

批准号:
82102938
项目类别:
青年科学基金项目(C类)
资助金额:
30.0 万元
负责人:
杜璟
依托单位:
学科分类:
肿瘤综合治疗
结题年份:
2024
批准年份:
2021
项目状态:
已结题
项目参与者:
杜璟

项目摘要

结项摘要

杜璟的其他基金

相似基金

相关文献

中文摘要
铁死亡是一种新发现的依赖铁的程序性死亡方式,其具体调控机制仍有待完善。现有研究表明RAS突变肿瘤细胞更易发生铁死亡,为靶向RAS突变的癌症疗法提供新的方向。我们已发表成果证实:具有调节铁稳态及氧化损伤功能的铁硫蛋白与铁死亡具有紧密的联系(Redox Biology, 2020)。我们最近发现:①在RAS突变细胞中敲低铁硫蛋白CISD2的表达可诱导铁死亡的发生;②敲低CISD2后,破坏线粒体稳态,线粒体能量代谢发生转变;③敲低CISD2激活自噬,下调Keap1-NRF2-FTH通路,促进自由铁的累积。因此,我们拟通过体内、外实验证实如下科学假说:CISD2蛋白缺失后通过线粒体代谢重编程,下调自噬介导的Keap-NRF2-FTH信号轴,诱导自由铁累积,激活铁死亡的发生。通过课题实施预期阐明CISD2调控铁死亡的机制,最终为开发相关的治疗方案提供新的思路和理论依据。
英文摘要
Ferroptosis is a newly discovered type of programmed cell death, with a typical characteristic of iron-dependent lipid peroxidation. However, the underlying mechanisms remain largely unknown and need further study. Previous studies have shown that RAS mutated tumor cells are more prone to ferroptosis, providing a new direction for cancer therapies targeting RAS mutations. Our published papers have evidenced that the iron-sulfur proteins with the function of regulating iron homeostasis and oxidative damage are closely associated with ferroptosis (Redox Biology, 2020). Furthermore, we recently found that (1) ferroptosis can be induced in RAS mutant cells by knockdown of iron-sulfur protein CISD2; (2) mitochondrial homeostasis was destroyed and energy metabolism was transformed in CISD2 knockdown cells; (3) autophagy was activated in CISD2 knockdown cells with the down-regulation of Keap1-NRF2-FTH pathway, promoting the accumulation of free iron. Therefore, through in vitro and in vivo experiments, we intend to confirm the hypothesis that CISD2 deletion down-regulates autophagy-mediated Keap1-NRF2-FTH axis through mitochondrial metabolic reprogramming, inducing free iron accumulation and ferroptotic cell death. Through the implementation of this project, we aim to clarify the mechanism of CISD2 regulating ferroptosis, providing a new idea and theoretical basis for the development of related therapies.
CISD2是一种对细胞增殖和铁稳态至关重要的铁硫蛋白,其异常表达与癌症进展有关。通过生物信息学分析,我们探索了CISD2蛋白质的相互作用和功能。实验表明,CISD2的敲低可增加脂质过氧化、GSH耗竭及自由铁的积累,进而促进Erastin诱导的铁死亡,而NRF2过表达则可抑制RAS突变肿瘤细胞对Erastin的敏感性。机制研究发现:CISD2敲低增强了溶酶体活性和铁蛋白降解,导致铁累积和铁死亡的发生。通过BafA1抑制溶酶体活性可以减轻铁死亡的发生。此外,CISD2敲低还通过促进p62降解、增加Keap1-NRF2结合导致NRF2泛素化和降解,促进铁死亡发生。过表达NRF2可以恢复铁死亡的表型,而Keap1的过表达则加剧了CISD2诱导的铁死亡。综上,我们发现抑制CISD2可通过自噬依赖性铁蛋白降解以及p62-Keap1-NRF2通路的下调来促进RAS突变肿瘤细胞铁死亡。在本青年项目资助下一共发表学术论文13篇,其中中科院一区文章6篇,IF>10分文章3篇,高被引文章2篇,二区文章13篇。
小分子抑制剂Thiotert通过TRX-NCOA4-FTH通路调控MDS细胞铁死亡
  • 批准号:
    LBY23H080005
  • 项目类别:
    省市级项目
  • 资助金额:
    0.0万元
  • 批准年份:
    2023
  • 负责人:
    杜璟
  • 依托单位:
国内基金
海外基金